Jillian N Simon1, Besarte Vrellaku1, Stefania Monterisi2, Sandy M Chu1, Nadiia Rawlings1, Oliver Lomas1, Gerard A Marchal1, Dominic Waithe3, Fahima Syeda4, Parag R Gajendragadkar1, Raja Jayaram1, Rana Sayeed5, Keith M Channon1, Larissa Fabritz4,6, Pawel Swietach2, Manuela Zaccolo2, Philip Eaton7, Barbara Casadei1. 1. Division of Cardiovascular Medicine, Radcliffe Department of Medicine (J.N.S., B.V., S.M.C., N.R., O.L., G.A.M., P.R.G., R.J., K.M.C., B.C.), University of Oxford, United Kingdom. 2. Department of Physiology, Anatomy and Genetics (S.M., P.S., M.Z.), University of Oxford, United Kingdom. 3. Wolfson Imaging Centre, Weatherall Institute of Molecular Medicine (D.W.), University of Oxford, United Kingdom. 4. Institute of Cardiovascular Sciences, University of Birmingham, United Kingdom (F.S., L.F.). 5. Cardiothoracic Surgery, Oxford Heart Centre, Oxford University Hospitals National Health Service Foundation Trust, United Kingdom (R.S.). 6. Department of Cardiology, University Hospitals Birmingham, United Kingdom (L.F.). 7. William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, United Kingdom (P.E.).
Abstract
BACKGROUND: Kinase oxidation is a critical signaling mechanism through which changes in the intracellular redox state alter cardiac function. In the myocardium, PKARIα (type-1 protein kinase A) can be reversibly oxidized, forming interprotein disulfide bonds in the holoenzyme complex. However, the effect of PKARIα disulfide formation on downstream signaling in the heart, particularly under states of oxidative stress such as ischemia and reperfusion (I/R), remains unexplored. METHODS: Atrial tissue obtained from patients before and after cardiopulmonary bypass and reperfusion and left ventricular (LV) tissue from mice subjected to I/R or sham surgery were used to assess PKARIα disulfide formation by immunoblot. To determine the effect of disulfide formation on PKARIα catalytic activity and subcellular localization, live-cell fluorescence imaging and stimulated emission depletion super-resolution microscopy were performed in prkar1 knock-out mouse embryonic fibroblasts, neonatal myocytes, or adult LV myocytes isolated from "redox dead" (Cys17Ser) PKARIα knock-in mice and their wild-type littermates. Comparison of intracellular calcium dynamics between genotypes was assessed in fura2-loaded LV myocytes, whereas I/R-injury was assessed ex vivo. RESULTS: In both humans and mice, myocardial PKARIα disulfide formation was found to be significantly increased (2-fold in humans, P=0.023; 2.4-fold in mice, P<0.001) in response to I/R in vivo. In mouse LV cardiomyocytes, disulfide-containing PKARIα was not found to impact catalytic activity, but instead led to enhanced AKAP (A-kinase anchoring protein) binding with preferential localization of the holoenzyme to the lysosome. Redox-dependent regulation of lysosomal two-pore channels by PKARIα was sufficient to prevent global calcium release from the sarcoplasmic reticulum in LV myocytes, without affecting intrinsic ryanodine receptor leak or phosphorylation. Absence of I/R-induced PKARIα disulfide formation in "redox dead" knock-in mouse hearts resulted in larger infarcts (2-fold, P<0.001) and a concomitant reduction in LV contractile recovery (1.6-fold, P<0.001), which was prevented by administering the lysosomal two-pore channel inhibitor Ned-19 at the time of reperfusion. CONCLUSIONS: Disulfide modification targets PKARIα to the lysosome, where it acts as a gatekeeper for two-pore channel-mediated triggering of global calcium release. In the postischemic heart, this regulatory mechanism is critical for protection from extensive injury and offers a novel target for the design of cardioprotective therapeutics.
BACKGROUND: Kinase oxidation is a critical signaling mechanism through which changes in the intracellular redox state alter cardiac function. In the myocardium, PKARIα (type-1 protein kinase A) can be reversibly oxidized, forming interprotein disulfide bonds in the holoenzyme complex. However, the effect of PKARIα disulfide formation on downstream signaling in the heart, particularly under states of oxidative stress such as ischemia and reperfusion (I/R), remains unexplored. METHODS: Atrial tissue obtained from patients before and after cardiopulmonary bypass and reperfusion and left ventricular (LV) tissue from mice subjected to I/R or sham surgery were used to assess PKARIα disulfide formation by immunoblot. To determine the effect of disulfide formation on PKARIα catalytic activity and subcellular localization, live-cell fluorescence imaging and stimulated emission depletion super-resolution microscopy were performed in prkar1 knock-out mouse embryonic fibroblasts, neonatal myocytes, or adult LV myocytes isolated from "redox dead" (Cys17Ser) PKARIα knock-in mice and their wild-type littermates. Comparison of intracellular calcium dynamics between genotypes was assessed in fura2-loaded LV myocytes, whereas I/R-injury was assessed ex vivo. RESULTS: In both humans and mice, myocardial PKARIα disulfide formation was found to be significantly increased (2-fold in humans, P=0.023; 2.4-fold in mice, P<0.001) in response to I/R in vivo. In mouse LV cardiomyocytes, disulfide-containing PKARIα was not found to impact catalytic activity, but instead led to enhanced AKAP (A-kinase anchoring protein) binding with preferential localization of the holoenzyme to the lysosome. Redox-dependent regulation of lysosomal two-pore channels by PKARIα was sufficient to prevent global calcium release from the sarcoplasmic reticulum in LV myocytes, without affecting intrinsic ryanodine receptor leak or phosphorylation. Absence of I/R-induced PKARIα disulfide formation in "redox dead" knock-in mouse hearts resulted in larger infarcts (2-fold, P<0.001) and a concomitant reduction in LV contractile recovery (1.6-fold, P<0.001), which was prevented by administering the lysosomal two-pore channel inhibitor Ned-19 at the time of reperfusion. CONCLUSIONS: Disulfide modification targets PKARIα to the lysosome, where it acts as a gatekeeper for two-pore channel-mediated triggering of global calcium release. In the postischemic heart, this regulatory mechanism is critical for protection from extensive injury and offers a novel target for the design of cardioprotective therapeutics.
Entities:
Keywords:
calcium signaling; lysosome; protein kinase A phosphorylation; redox; reperfusion injury
Authors: Pamela W M Kleikers; K Wingler; J J R Hermans; I Diebold; S Altenhöfer; K A Radermacher; B Janssen; A Görlach; H H H W Schmidt Journal: J Mol Med (Berl) Date: 2012-10-23 Impact factor: 4.599
Authors: Ganapathy N Sarma; Francis S Kinderman; Choel Kim; Sventja von Daake; Lirong Chen; Bi-Cheng Wang; Susan S Taylor Journal: Structure Date: 2010-02-10 Impact factor: 5.006
Authors: Sean M Davidson; Kirsty Foote; Suma Kunuthur; Raj Gosain; Noah Tan; Richard Tyser; Yong Juan Zhao; Richard Graeff; A Ganesan; Michael R Duchen; Sandip Patel; Derek M Yellon Journal: Cardiovasc Res Date: 2015-09-22 Impact factor: 10.787
Authors: Daniel Aston; Rebecca A Capel; Kerrie L Ford; Helen C Christian; Gary R Mirams; Eva A Rog-Zielinska; Peter Kohl; Antony Galione; Rebecca A B Burton; Derek A Terrar Journal: Sci Rep Date: 2017-01-17 Impact factor: 4.379
Authors: Friederike Cuello; Friedrich W Herberg; Konstantina Stathopoulou; Philipp Henning; Simon Diering Journal: Antioxidants (Basel) Date: 2021-04-24
Authors: M M Towhidul Islam; Daniel Tarnowski; Min Zhang; Maximilian Trum; Simon Lebek; Julian Mustroph; Henriette Daniel; Johanna Moellencamp; Steffen Pabel; Samuel Sossalla; Ali El-Armouche; Viacheslav O Nikolaev; Ajay M Shah; Philip Eaton; Lars S Maier; Can Martin Sag; Stefan Wagner Journal: J Am Heart Assoc Date: 2021-09-29 Impact factor: 5.501
Authors: Nir Qvit; Amanda J Lin; Aly Elezaby; Nicolai P Ostberg; Juliane C Campos; Julio C B Ferreira; Daria Mochly-Rosen Journal: Pharmaceuticals (Basel) Date: 2022-02-22